Form 4: USANA Health Sciences Director Acquires Restricted Stock Units

Director Frederic J. Winssinger acquired 2,697 restricted stock units in USANA Health Sciences Inc. on May 2, 2024.

Summary

• On May 2, 2024, Frederic J. Winssinger, a director of USANA Health Sciences Inc., acquired 2,697 restricted stock units.
• These restricted stock units represent a contingent right to receive one share of USNA common stock each.
• The units vest in four equal installments: 25% on August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.
• Following the transaction, Winssinger directly owns 2,697 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating a director's acquisition of restricted stock units, which is generally a positive sign but doesn't provide enough information to strongly influence sentiment.

Positives

• The acquisition of restricted stock units by a director signals confidence in the company's future performance.

Future Outlook

The vesting schedule indicates a long-term commitment by the director to the company's success.

Industry Context

Insider transactions are closely monitored as indicators of management's perspective on the company's valuation and prospects. Restricted stock units are a common form of executive compensation in the health sciences industry.

Comparison to Industry Standards

• Comparing USANA's executive compensation structure to companies like Herbalife Nutrition and Nu Skin Enterprises would provide a benchmark for assessing the competitiveness and alignment of incentives.
• Analyzing the vesting schedules and equity grants of directors in similar-sized companies within the nutritional supplement industry can offer insights into industry norms.

Stakeholder Impact

• The acquisition of restricted stock units by a director can positively influence shareholder sentiment.

Key Dates